ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,307.00
-1.33%
S&P ASX All Technology
4,090.00
-1.02%
Brent Oil
75.515
-0.40%
US Dollar vs AUD
1.57432
-0.20%
Bitcoin
97,048.24
0.43%
Pepperstone
Advertisement
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Abionyx Pharma (ABNX) Share Price

Abionyx Pharma

Abionyx Pharma (ABNX)

EU
1.26
0.024
(1.94%)
Closed 20 February 3:30AM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
1.26
Bid
1.21
Offer
1.26
Volume
35,629
1.22 Day's Range 1.262
0.91 52 Week Range 1.50
Market Cap
40.898M
Previous Close
1.236
Open
1.236
Last Trade
55
@
1.26
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
33,553
Shares Outstanding
32,459,012
Dividend Yield
-
PE Ratio
-11.62
Earnings Per Share (EPS)
-0.11
Revenue
4.74M
Net Profit
-3.52M

About Abionyx Pharma

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.abionyx.com
Headquarters
Balma, Haute-garonne, Fra
Founded
-
Abionyx Pharma is listed in the Pharmaceutical Preparations sector of the Euronext with ticker ABNX. The last closing price for Abionyx Pharma was 1.24 €. Over the last year, Abionyx Pharma shares have traded in a share price range of 0.91 € to 1.50 €.

Abionyx Pharma currently has 32,459,012 shares in issue. The market capitalisation of Abionyx Pharma is 40.12 € million. Abionyx Pharma has a price to earnings ratio (PE ratio) of -11.62.

Ask ADVFN Intelligence (AI)

ABNX Latest News

More News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.0141.123595505621.2461.2841.194416601.23860334DE
4-0.01-0.7874015748031.271.2841.19271501.23249135DE
12-0.012-0.9433962264151.2721.351.16335531.26227032DE
26-0.1-7.352941176471.361.51.128379861.28159347DE
520.0651.21.50.91464901.22401731DE
156-0.6-32.25806451611.862.6150.91878101.66039322DE
2600.262613.570.382258931.48436957DE

ABNX - Frequently Asked Questions (FAQ)

What is the current Abionyx Pharma share price?
The current share price of Abionyx Pharma is 1.26 €
How many Abionyx Pharma shares are in issue?
Abionyx Pharma has 32,459,012 shares in issue
What is the market cap of Abionyx Pharma?
The market capitalisation of Abionyx Pharma is EUR 40.12M
What is the 1 year trading range for Abionyx Pharma share price?
Abionyx Pharma has traded in the range of 0.91 € to 1.50 € during the past year
What is the PE ratio of Abionyx Pharma?
The price to earnings ratio of Abionyx Pharma is -11.62
What is the cash to sales ratio of Abionyx Pharma?
The cash to sales ratio of Abionyx Pharma is 8.64
What is the reporting currency for Abionyx Pharma?
Abionyx Pharma reports financial results in EUR
What is the latest annual turnover for Abionyx Pharma?
The latest annual turnover of Abionyx Pharma is EUR 4.74M
What is the latest annual profit for Abionyx Pharma?
The latest annual profit of Abionyx Pharma is EUR -3.52M
What is the registered address of Abionyx Pharma?
The registered address for Abionyx Pharma is 33-43 AVENUE GEORGES POMPIDOU, BATIMENT D, BALMA, HAUTE-GARONNE, 31130
What is the Abionyx Pharma website address?
The website address for Abionyx Pharma is www.abionyx.com
Which industry sector does Abionyx Pharma operate in?
Abionyx Pharma operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ARFDSAdeunis DS
0.11 €
(120.00%)
23.38k
MLSMLSmalto
0.029 €
(107.14%)
201.11k
ALCYBCybergun
0.0002 €
(100.00%)
23.89M
ALBDMBD Multi-Media
1.16 €
(51.83%)
16.98k
ALVERVergnet
0.0006 €
(50.00%)
65.8M
CYADCelyad Oncology SA
0.55 €
(-28.57%)
510.46k
BAIOdyssey Acquisition SA
0.18 €
(-21.40%)
309.24k
REALRealco NV
15.00 €
(-21.05%)
400
ALADOAdomos
0.33 €
(-17.50%)
27.66k
ALAMAAMA Corporation PLC
0.187 €
(-16.89%)
159.09k
ATOAtos SE
0.0032 €
(-5.88%)
3.41B
ALVERVergnet
0.0006 €
(50.00%)
65.8M
BCPBanco Comercial Portugues SA
0.5422 €
(-1.20%)
64.52M
ALHPIHopium SA
0.0028 €
(7.69%)
43.47M
ALEUPEuroplasma
0.0114 €
(-9.52%)
23.92M

Discussion

View Full Feed
DHANA DHANA 2 minutes ago
$MCIC Website coming soon.
https://multicorpinternationalinc.com/
MCIC
Cassius Longinus Cassius Longinus 4 minutes ago
Ole BeaMed now hiring a mechanical engineer as of a day ago.
IPIX
trade15 trade15 4 minutes ago
Janice
Seems spellchecker had a mind of its own this morning. A post to Homebrew ended up as Home brand. A friend of mine was in a rush to go look at a race horse this morning so I wasn't paying attention to what was posted. Seems you got Plant Micrcap Showcase instead of Planet Microcap .
XMaster2023 XMaster2023 5 minutes ago
Gotta be kidding me? What market do you believe they will go after? How about starting in the UK and Canada going after the rGBM and nGBM market?
NWBO
janice shell janice shell 6 minutes ago
Damn, Reyes is good! What happened next?
236T568 236T568 6 minutes ago
So much winning

https://bsky.app/profile/rpsagainsttrump.bsky.social/post/3lilczvnnkk2q
EternalPatience EternalPatience 8 minutes ago
His tweet from 2 days ago is propping Sr preferred. The chameleon is changing colors again
FNMA
BDEZ BDEZ 8 minutes ago
This Nugent clip needs rewatching over & over

https://x.com/BGatesIsaPyscho/status/1892007496950104391
Judah137 Judah137 9 minutes ago
Hahahaha, Hyperion is ALWAYS right! Filthy Jose!!
NEWH
JohnnyBlaze JohnnyBlaze 9 minutes ago
Picking up nice hopefully that means we are closer to something big happening 
SYIN
808mark 808mark 9 minutes ago
So inspiring. Get off the LQMT stupid already
LQMT
Green Leaf Smoker Green Leaf Smoker 9 minutes ago
This is what one is relying on to prop up this POS play 💩MJNA💩???🤣😂
Fundamentals in this POS play R💩 because their is none. Lot of SELLERS @ O.OOO3 R lining (💩ing) up today that r stuck in MJNA, their major problem is few to no buyers r lining
MJNA
nowwhat2 nowwhat2 10 minutes ago
No longer stuck in the middle w you..........96,888


https://investorshub.advfn.com/uimage/uploads/2025/2/19/nhbo[btc_@_19_snip_6pm_96888.jpg


https://www.youtube.com/watch?v=OMAIsqvTh7g




OTH ;


h
BTCUSD
StockHobit StockHobit 10 minutes ago
Does an audit really matter at this point of dwindling style="font-size: 1em" revenues and increased share selling and debt to keep things afloat.   
IBGR
biowin biowin 10 minutes ago
https://www.justice.gov/archives/opa/pr/justice-department-sues-kkr-serial-violations-federal-premerger-review-law
808mark 808mark 10 minutes ago
Yeah you are. Don’t sell yourself or your losses
LQMT
808mark 808mark 11 minutes ago
Yeah you are. Don’t sell yourself or your losses
LQMT
JohnnyBlaze JohnnyBlaze 11 minutes ago
Look at filing today very bullish
IFXY
Kool Aid Man Kool Aid Man 11 minutes ago
I invite you to learn IHub's rules about your complaints. Avail yourself of the following links at the bottom of every page

FAQ
Handbook
Q&A Forum
Contact Us
SPZI
dukeb dukeb 12 minutes ago
There is non-resident commuter parking at the Tarrytown Metro North Station.
Rkramden Rkramden 14 minutes ago
Not to shabby backers


https://www.franciscopartners.com/team/peter-gingold

Your Recent History

EU
ABNX
Abionyx Pharma
EU
AVIAW
Actiam Beleggingsfondsen...
TG
ASRT
BNP Paribas Asset Manage...
USOTC
FCNCB
First Citizen Bancshares (PK)
LSE
0XAK
Lyxor Ftse Epra/nareit G...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads